TuisUTHR • NASDAQ
add
United Therapeutics Corp
Vorige sluiting
$296,42
Dagwisseling
$286,93 - $293,74
Jaarwisseling
$233,31 - $417,82
Markkapitalisasie
13,09 mjd USD
Gemiddelde volume
458,24 k
P/V-verhouding
11,82
Dividend-opbrengs
-
Primêre beurs
NASDAQ
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Des. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 735,90 m | 19,72% |
Bedryfskoste | 298,10 m | 5,52% |
Netto inkomste | 301,30 m | 38,78% |
Netto winsgrens | 40,94 | 15,91% |
Wins per aandeel | 6,19 | 41,97% |
EBITDA | 381,60 m | 38,81% |
Effektiewe belastingkoers | 24,01% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Des. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 3,27 mjd | 9,11% |
Totale bates | 7,36 mjd | 2,75% |
Totale aanspreeklikheid | 920,00 m | -22,18% |
Totale ekwiteit | 6,44 mjd | — |
Uitstaande aandele | 44,91 m | — |
Prys om te bespreek | 2,06 | — |
Opbrengs op bates | 12,49% | — |
Opbrengs op kapitaal | 13,62% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Des. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | 301,30 m | 38,78% |
Kontant van bedrywe | 341,20 m | 126,41% |
Kontant van beleggings | -123,20 m | -392,64% |
Kontant van finansiering | -74,70 m | 19,50% |
Netto kontantverandering | 143,30 m | 43,30% |
Beskikbare kontantvloei | 206,85 m | 124,32% |
Meer oor
United Therapeutics Corporation is an American biotechnology company that develops pharmaceuticals and technologies related to organ transplantation, including xenotransplantation. Many of the company's products are focused towards lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; and Manchester, New Hampshire. Wikipedia
Gestig
1996
Webwerf
Werknemers
1 305
